Te AE - Search Results

1

Use of the Bulbocavernosus Reflex System in assessing voiding dysfunction.

Laudano MA, Chughtai B, Lee RK, Seklehner S, Elterman D, Kaplan SA, Te AE. Laudano MA, et al. Among authors: te ae. World J Urol. 2013 Dec;31(6):1459-62. doi: 10.1007/s00345-013-1063-x. Epub 2013 Mar 24. World J Urol. 2013. PMID: 23525787

2

Is the higher prevalence of benign prostatic hyperplasia related to lower urinary tract symptoms in Korean men due to a high transition zone index?

Choi J, Ikeguchi EF, Lee SW, Choi HY, Te AE, Kaplan SA. Choi J, et al. Among authors: te ae. Eur Urol. 2002 Jul;42(1):7-11. doi: 10.1016/s0302-2838(02)00222-1. Eur Urol. 2002. PMID: 12121722

3

PSA response to finasteride challenge in men with a serum PSA greater than 4 ng/ml and previous negative prostate biopsy: preliminary study.

Kaplan SA, Ghafar MA, Volpe MA, Lam JS, Fromer D, Te AE. Kaplan SA, et al. Among authors: te ae. Urology. 2002 Sep;60(3):464-8. doi: 10.1016/s0090-4295(02)01760-0. Urology. 2002. PMID: 12350485 Clinical Trial.

4

Overactive bladder and men: indications for anticholinergics.

González RR, Te AE. González RR, et al. Among authors: te ae. Curr Urol Rep. 2003 Dec;4(6):429-35. doi: 10.1007/s11934-003-0022-2. Curr Urol Rep. 2003. PMID: 14622494 Review.

5

A prospective, 1-year trial using saw palmetto versus finasteride in the treatment of category III prostatitis/chronic pelvic pain syndrome.

Kaplan SA, Volpe MA, Te AE. Kaplan SA, et al. Among authors: te ae. J Urol. 2004 Jan;171(1):284-8. doi: 10.1097/01.ju.0000101487.83730.80. J Urol. 2004. PMID: 14665895 Clinical Trial.

6

Photoselective vaporization of the prostate for the treatment of benign prostatic hyperplasia: 12-month results from the first United States multicenter prospective trial.

Te AE, Malloy TR, Stein BS, Ulchaker JC, Nseyo UO, Hai MA, Malek RS. Te AE, et al. J Urol. 2004 Oct;172(4 Pt 1):1404-8. doi: 10.1097/01.ju.0000139541.68542.f6. J Urol. 2004. PMID: 15371855 Clinical Trial.

7

Chronic prostatitis and sensory urgency: whose pain is it?

Gonzalez RR, Te AE. Gonzalez RR, et al. Among authors: te ae. Curr Urol Rep. 2004 Dec;5(6):437-41. doi: 10.1007/s11934-004-0067-x. Curr Urol Rep. 2004. PMID: 15541212 Review.

8

High-power potassium-titanyl-phosphate photoselective laser vaporization of prostate for treatment of benign prostatic hyperplasia in men with large prostates.

Sandhu JS, Ng C, Vanderbrink BA, Egan C, Kaplan SA, Te AE. Sandhu JS, et al. Among authors: te ae. Urology. 2004 Dec;64(6):1155-9. doi: 10.1016/j.urology.2004.07.018. Urology. 2004. PMID: 15596189 Clinical Trial.

9

Tolterodine extended release attenuates lower urinary tract symptoms in men with benign prostatic hyperplasia.

Kaplan SA, Walmsley K, Te AE. Kaplan SA, et al. Among authors: te ae. J Urol. 2005 Dec;174(6):2273-5. discussion 2275-6. doi: 10.1097/01.ju.0000181823.33224.a0. J Urol. 2005. PMID: 16280803

10

Photoselective laser vaporization prostatectomy in men receiving anticoagulants.

Sandhu JS, Ng CK, Gonzalez RR, Kaplan SA, Te AE. Sandhu JS, et al. Among authors: te ae. J Endourol. 2005 Dec;19(10):1196-8. doi: 10.1089/end.2005.19.1196. J Endourol. 2005. PMID: 16359214

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

196 results

Search Page

Filters